Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.

Trebosc V, Gartenmann S, Tötzl M, Lucchini V, Schellhorn B, Pieren M, Lociuro S, Gitzinger M, Tigges M, Bumann D, Kemmer C.

mBio. 2019 Jul 16;10(4). pii: e01083-19. doi: 10.1128/mBio.01083-19.

2.

A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2.

Prevet H, Moune M, Tanina A, Kemmer C, Herledan A, Frita R, Wohlkönig A, Bourotte M, Villemagne B, Leroux F, Gitzinger M, Baulard AR, Déprez B, Wintjens R, Willand N, Flipo M.

Eur J Med Chem. 2019 Apr 1;167:426-438. doi: 10.1016/j.ejmech.2019.02.023. Epub 2019 Feb 10.

PMID:
30784877
3.

Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420.

Blondiaux N, Moune M, Desroses M, Frita R, Flipo M, Mathys V, Soetaert K, Kiass M, Delorme V, Djaout K, Trebosc V, Kemmer C, Wintjens R, Wohlkönig A, Antoine R, Huot L, Hot D, Coscolla M, Feldmann J, Gagneux S, Locht C, Brodin P, Gitzinger M, Déprez B, Willand N, Baulard AR.

Science. 2017 Mar 17;355(6330):1206-1211. doi: 10.1126/science.aag1006. Epub 2017 Mar 16.

PMID:
28302858
4.

A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.

Trebosc V, Gartenmann S, Royet K, Manfredi P, Tötzl M, Schellhorn B, Pieren M, Tigges M, Lociuro S, Sennhenn PC, Gitzinger M, Bumann D, Kemmer C.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7263-7271. Print 2016 Dec.

5.

BioVersys Works to Bring Antibiotic Resistance to an End.

Tigges M, Gitzinger M.

Chimia (Aarau). 2014 Dec;68(12):888-90. doi: 10.2533/chimia.2014.888.

PMID:
26508613
6.

The food additive vanillic acid controls transgene expression in mammalian cells and mice.

Gitzinger M, Kemmer C, Fluri DA, El-Baba MD, Weber W, Fussenegger M.

Nucleic Acids Res. 2012 Mar;40(5):e37. doi: 10.1093/nar/gkr1251. Epub 2011 Dec 19.

7.

Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis.

Grau T, Selchow P, Tigges M, Burri R, Gitzinger M, Böttger EC, Fussenegger M, Sander P.

Antimicrob Agents Chemother. 2012 Feb;56(2):1142-5. doi: 10.1128/AAC.05649-11. Epub 2011 Nov 21.

8.

Self-sufficient control of urate homeostasis in mice by a synthetic circuit.

Kemmer C, Gitzinger M, Daoud-El Baba M, Djonov V, Stelling J, Fussenegger M.

Nat Biotechnol. 2010 Apr;28(4):355-60. doi: 10.1038/nbt.1617. Epub 2010 Mar 28.

PMID:
20351688
9.

Controlling transgene expression in subcutaneous implants using a skin lotion containing the apple metabolite phloretin.

Gitzinger M, Kemmer C, El-Baba MD, Weber W, Fussenegger M.

Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10638-43. doi: 10.1073/pnas.0901501106. Epub 2009 Jun 22.

10.

Functional cross-kingdom conservation of mammalian and moss (Physcomitrella patens) transcription, translation and secretion machineries.

Gitzinger M, Parsons J, Reski R, Fussenegger M.

Plant Biotechnol J. 2009 Jan;7(1):73-86. doi: 10.1111/j.1467-7652.2008.00376.x. Epub 2008 Oct 8. Erratum in: Plant Biotechnol J. 2009 Feb;7(2):210.

11.

A synthetic mammalian gene circuit reveals antituberculosis compounds.

Weber W, Schoenmakers R, Keller B, Gitzinger M, Grau T, Daoud-El Baba M, Sander P, Fussenegger M.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):9994-8. doi: 10.1073/pnas.0800663105. Epub 2008 Jul 9.

12.

Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis, and estrogenic outcomes in healthy postmenopausal women: a phase I clinical trial.

Pop EA, Fischer LM, Coan AD, Gitzinger M, Nakamura J, Zeisel SH.

Menopause. 2008 Jul-Aug;15(4 Pt 1):684-92. doi: 10.1097/gme.0b013e318167b8f2.

Supplemental Content

Loading ...
Support Center